Navigation Links
Latest NIMH Study on Bipolar Disorder

ily members.

This study concludes what NAMI members have known for years -- a combination of intensive psychosocial interventions and family involvement are both necessary ingredients for the best outcomes in bipolar disorder. Unfortunately many people who live with serious mental illnesses, like bipolar disorder, don't have access to the most basic care, much less the intensive psychosocial interventions recommended in the study.

The medication arm of the study, released last week in the New England Journal of Medicine, looked at two commonly prescribed antidepressants along with mood stabilizers for the symptoms of depression in individuals who have a diagnosis of bipolar disorder. The study found that the two antidepressants they studied did not work to relieve the depressive symptoms of the illness any better than placebo did for people with bipolar illness. The depressive phase of bipolar illness is notoriously difficult to treat, and more will have to be uncovered as to which pharmacologic strategies best complement the psychosocial treatments for this aspect of bipolar disorder. Most people with bipolar illness spend much more time in the depressive phase, so the need for more effective treatments is profound.

What we learn from these studies is that the treatment of bipolar disorder is an important public health concern, and one that demands individualized attention. We need to provide greater access to intensive psychotherapy to truly offer the hope of recovery to millions of Americans living with bipolar disorder."

Archives of General Psychiatry: http://archpsyc.ama-assn.org/


    New England Journal of Medicine article:

http://content.nejm.org/cgi/content/full/NEJMoa064135

CONTACT: Alexis O'Brien of NAMI, +1-703-312-7893

Web site: '"/>




Page: 1 2 3

Related medicine technology :

1. Alfacells Onconase Highlighted in Latest Edition of Handbook of Therapeutic Antibodies
2. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
3. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
4. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
5. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
6. Reaction to Avandia Warnings Stronger Among Internists Than Endocrinologists, According to Study by GfK Market Measures
7. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
8. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
9. Protox Announces Positive Clinical Data from Prostate Cancer Study
10. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
11. New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Latest NIMH Study Bipolar Disorder
(Date:11/23/2009)...linker.comannouncesthatanewmarketresearchreportisa...es-AWorldMarketReview ,, http://www.reportli...-Market-Review.html#utm_source=prnewswire&utm_...obalgeneralanesthesiadisposablesmarketischaracteri...erisewitnessedingeneralsurgicalprocedures,growingp...
(Date:11/23/2009)...l/-- CryoLife,Inc. (NYSE: CRY ),animplantablebiolo...gcompany,announcedtodaythatitisscheduledtoparticip...nferenceatTheNewYorkPalaceHotelonDecember1,2009. ,...ficerofCryoLife,Inc.,willprovideacorporateoverview...tionandanswersessionat4:30p.m.EasternTime. ,, C...
(Date:11/23/2009)...e/--Sarnova,Inc.,thenation,sleadingspecialtydistri...ices(EMS)andrespiratorymarkets,announcedtodaythati...am.ThenewexecutivesincludeTomDavid,executivevicepr...generalcounsel;SteveLacke,executivevicepresidentof...ofcorporatedevelopment. ,, "Ihaveworkedwithallo...
Breaking Medicine Technology:Reportlinker Adds Anesthesia Disposables - A World Market Review 2Reportlinker Adds Anesthesia Disposables - A World Market Review 3Reportlinker Adds Anesthesia Disposables - A World Market Review 4Reportlinker Adds Anesthesia Disposables - A World Market Review 5Reportlinker Adds Anesthesia Disposables - A World Market Review 6CryoLife to Present at 21st Annual Piper Jaffray Health Care Conference 2Sarnova Expands Senior Management Team 231 Breast Cancer Myths 26amp 3B Truths in 31 Days 58811 131 Breast Cancer Myths 26amp 3B Truths in 31 Days 58811 2Senate Committee Addresses Some Issues On Affordability Fails To Correct Abortion Problems And Immigration Concerns Say USCCB Officials 58808 1Senate Committee Addresses Some Issues On Affordability Fails To Correct Abortion Problems And Immigration Concerns Say USCCB Officials 58808 2You Can Thrive 21 Burlesque Show Celebrates the Girls and the Women Who Are Battling to Keep Them 58805 1You Can Thrive 21 Burlesque Show Celebrates the Girls and the Women Who Are Battling to Keep Them 58805 2
...gical Therapeutics, Inc.,announced today the comme...trolled, multinational study of LT-NS001, a novel ...naproxen, a non-steroidal,anti-inflammatory drug (...en worldwide for the treatment of pain, inflammati... arthritis (RA) and osteoarthritis,(OA)., "Despit...
...otope Based Delivery System Has Potential to, Help...arities Reported at AS... experience with the,FDA cleared Axxent(R) Electro...tes that the X-Ray-based, non-isotopic treatment i...tage breast cancer. Initial data,from this multi-c...
Other Medicine Technology:Logical Therapeutics Inc. Commences Double-Blind, Randomized Study of Their Lead Program, LT-NS001 2Electronic Brachytherapy a Viable Option for Early Stage Breast Cancer, According to Study Presented at ASCO Breast Cancer Symposium 2Electronic Brachytherapy a Viable Option for Early Stage Breast Cancer, According to Study Presented at ASCO Breast Cancer Symposium 3Electronic Brachytherapy a Viable Option for Early Stage Breast Cancer, According to Study Presented at ASCO Breast Cancer Symposium 4
(Date:11/24/2009)... NCL Security Launches EyeCentral Remote Video Pla...ing Monthly Revenue for Central Stations and Secur...xas (PRWEB) November 24, 2009 -- NCL Security Laun...rity Industry to Generate Recurring Monthly Revenu...quot;Integrated security systems has been and stil...
(Date:11/24/2009).../PRNewswire-USNewswire/--Newpeer-revieweddatafindi...nsinfectedwithchronichepatitisCvirushavereceivedan...atCongressneedstomoveurgentlyonbipartisanlegislati...veillanceefforts,the NationalViralHepatitisRoundta...congressionalaction,millionsofAmericansinfectedwit...
(Date:11/23/2009)...iversity of Michigan determined that only 663,000 ...patitis C virus (HCV) infection received antiviral...ppear to be declining, in part because only half o...sturbing trend continues, by 2030 less than 15% of...y antiviral therapy. This study, the first to ana...
(Date:11/23/2009),, NEWYORK,Nov.23/PRNewswire/--Livingwithchronicpaincanbedifficult-andthestressoftheholidayseasoncanprovetobequitechallengingforthoselivingwithpain. ,, ListentothisreportfromPfizerInc.at: ,
(Date:11/23/2009)...the hook for the high cost of drug advertising tha...tudy led by a University of British Columbia healt...ay in the Archives of Internal Medicine , examine...ing drug also known by the trade name Plavix used ...e. The drug was selected to study the impact of ad...
Breaking Medicine News(10 mins):Health News:NCL Security Launches EyeCentral Video Platform for the Security Industry to Generate Recurring Monthly Revenue for Central Stations and Security Dealers 2Health News:NVHR: New Data Finding Fewer than 1 in 5 Hepatitis C Patients Receiving Antiviral Therapy is 'Wake-Up Call' for Washington 2Health News:Alarming trend -- antiviral therapy to treat hepatitis C is declining in the US 2Health News:Drug ads ineffective for boosting sales, could cost taxpayers: UBC-Harvard study 2
...ems, Inc.,(NYSE: DST ) will release its financial...08, on Tuesday, July 22, 2008, after the close of ...any will host a conference call on Wednesday, July...rnational,callers, the dial-in number is (612) 234...
...iming June,20 Donated Dental Services (DDS) Progra...l acknowledged the significant charitable contribu...) members across the state., "We are extremely pl...he inception of the Pennsylvania DDS,program in 19...
... immune system , , TUESDAY, June 24 (Healt...etastatic colon cancer appears to work in mice, r...operty: It acts on the immune system in the intes...one and one in the gut," said lead researcher Dr. ...
... Protect Patient Access To Community,Pharmacies, ...entatives voted 355 to 59 in favor of H.R. 6331, w...care bill contains three critical,provisions for c...ment that would have driven thousands of,community...
...bare metal devices, study suggests , , TUE...ho got drug-coated stents did better than those wh...tudy found. , But it isn,t a simple either-or issu... October 2002 and March 2003, when only bare-metal...
...ordering supplies has helped Geisinger cut $30 mil...rs, made it easier to recall medications in the ev...uplication of many products. , Geisinger,s Supp...ovation Award from the Premier healthcare alliance...
Other Medicine News:Health News:DST Systems, Inc. Announces Notification of Earnings Release Date 2Health News:Governor Lauds Pennsylvania Dental Association Member Participation in Donated Dental Services Program 2Health News:Vaccine Stops Colon Cancer's Spread in Mice 2Health News:Drug-Coated Stents Reduce Repeat Artery Procedures 2Health News:Drug-Coated Stents Reduce Repeat Artery Procedures 3Health News:Geisinger saves millions in medical dollars through better supply management 2
...ies is a national reference laboratory and a world...development. ARUP offers an extensive test menu of...al and anatomic pathology. Owned by the University...than half of the nation's university teaching hosp...
...ies is a national reference laboratory and a world...development. ARUP offers an extensive test menu of...al and anatomic pathology. Owned by the University...than half of the nation's university teaching hosp...
...ies is a national reference laboratory and a world...development. ARUP offers an extensive test menu of...al and anatomic pathology. Owned by the University...than half of the nation's university teaching hosp...
...ies is a national reference laboratory and a world...development. ARUP offers an extensive test menu of...al and anatomic pathology. Owned by the University...than half of the nation's university teaching hosp...
Medicine Products: